'Chronic gvhd' diaporamas de présentation

2012 The UK Photopheresis Society

1.45k views • 121 slides

Chronic Graft versus Host Disease Examples

Chronic Graft versus Host Disease Examples. May 28, 2012. Example # 1. Diane is a 36 year old On her clinic note you find the following: Maculopapular rash on her face and upper chest (15% BSA) Food sensitivity, lichen planus-like oral changes on physical exam

1.19k views • 75 slides

Allogeneic Hematopoietic Stem Cell Transplant for the Medical Oncologist

Allogeneic Hematopoietic Stem Cell Transplant for the Medical Oncologist. John Kuruvilla MD FRCPC. Objectives. Understand basic principles of Allogeneic Transplant: Types of Preparative Regimens Stem Cell Source Donor Types. Hematopoietic Stem Cell Transplantation.

1.43k views • 49 slides

747 views • 46 slides

Is allo-SCT first line option for AA if sibling donor available?

569 views • 45 slides

Everything You Ever Wanted to Know About Transplant But Were Afraid to Ask

Everything You Ever Wanted to Know About Transplant But Were Afraid to Ask. Jeffrey Schriber, M.D. FRCP ( c ) Medical Director Cancer Transplant Institute Virginia G. Piper Cancer Center. Suddenly, Dr. Schriber realized he had left his brain in Toronto. Objectives.

509 views • 38 slides

The New Study Worksheets !

512 views • 36 slides

Host

(I) Conditioning. Tissue Damage. Host. Small. tissues. intestine. LPS. TNF- a IL-1 LPS. f. M. APC. TNF- a IL-1. CD4 CTL. IFN- g. Donor. T Cell. Target cell apoptosis. (III). (II). CD8 CTL. Cellular and. Donor. TNF- a IL-1. inflammatory. T-cell. Th. 1. CD8 CTL.

403 views • 24 slides

313 views • 18 slides

Supported by Czech Govt. Funding MSM 6198959205 and IGA MZ CR NR 9099

MADCAM1 GENE POLYMORPHISMS AND THE OUTCOME OF THE ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION. Z. Ambruzova 1 , F. Mrazek 1 , L. Raida 2 , A. Stahelova 1 , E. Faber 2 , K. Indrak 2 , M. Petrek 1

258 views • 13 slides

Disclosures

Disclosures. Philip L. McCarthy Jr. BMT Program Roswell Park Cancer Institute, Buffalo, NY Participated in Dor Pharma acute Graft-versus-Host Disease (GvHD) Phase III study examining beclomethasone diproprionate (BDP) Involved in the design of future large chronic GvHD study

209 views • 5 slides

Graft versus Host Disease (GVHD) Market Insights, Epidemiology and Market Report 2023

Graft versus Host Disease (GVHD) Market Report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for the forecast period (2013-2023). For more detail click the Official URL below http://www.marketresearchhub.com/report/graft-versus-host-disease-gvhd-market-insights-epidemiology-and-market-forecast-2023-eu5-report.html

103 views • 3 slides